Skip to main content

Advertisement

Contact Haiqiang Mai

From: Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Contact corresponding author